Communiqués Chimeric Therapeutics Limited

Actions

Marché Fermé - Australian S.E. 07:59:39 18/09/2026			Varia. 5j.	Varia. 1 janv.
0,006000 ^AUD	0,00%		-25,00%	-97,00%

31/08	Chimeric Therapeutics Limited publie ses résultats pour l'exercice clos le 30 juin 2026	CI
31/08	Transcript : Chimeric Therapeutics Limited - Special Call

05/06/23	Chimeric Therapeutics To Attend BIO International Convention	AQ
05/06/23	Chimeric Announces Launch of New Phase 1B Glioblastoma Clinical Trial	AQ
27/04/23	Chimeric Therapeutics thrilled with ethics approval for brain cancer study	AQ
15/06/22	Chimeric Therapeutics : Application for quotation of securities - CHM	PU
12/04/22	Chimeric enters strategic manufacturing partnership with WuXi Advanced Therapies	GL
25/03/22	Chimeric Therapeutics : Appendix 2A	PU
08/03/22	Chimeric Therapeutics : Appendix 3B (amended)	PU
06/03/22	Chimeric Therapeutics : CORE NK Platform Phase 1 Clinical Data Presentation	PU
22/02/22	Chimeric Therapeutics : Appendix 3B (amended)	PU
22/02/22	Chimeric Therapeutics : Investor Presentation - Entitlement Offer	PU
21/02/22	Chimeric Therapeutics : Prospectus	PU
21/02/22	Chimeric Therapeutics : Appendix 3B	PU
06/02/22	Chimeric Therapeutics : Notification regarding unquoted securities - CHM	PU
14/12/21	Chimeric Therapeutics : Change of Director's Interest Notice - JC, CE & GM	PU
06/12/21	Chimeric Therapeutics : Application for quotation of securities - CHM	PU
03/12/21	Chimeric Therapeutics : Notification regarding unquoted securities - CHM	PU
03/12/21	Chimeric Therapeutics : Application for quotation of securities - CHM	PU
01/12/21	Chimeric Transforms Portfolio With a Clinically Validated, Off the Shelf, Natural Killer (NK) Cell Platform	GL
30/11/21	Chimeric Therapeutics : Transformative Portfolio Expansion Presentation	PU
21/11/21	Chimeric Therapeutics : AGM Presentation	PU